DUBLIN–(BUSINESS WIRE)–The “Blood Glucose Meters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update” report has been added to ResearchAndMarkets.com’s offering.
“Blood Glucose Meters Pipeline Report” provides comprehensive information about the Blood Glucose Meters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
This report offers extensive coverage of Blood Glucose Meters currently under development, encompassing a thorough examination of major pipeline products with detailed descriptions, licensing and collaboration details, and other pertinent developmental activities. It also delves into the major players actively engaged in the advancement of Blood Glucose Meters, shedding light on their respective pipeline projects and contributions to the industry.
The report categorizes these pipeline products based on their developmental stages, spanning from Early Development to Approved/Issued stages, providing insights into their progress and maturity. Furthermore, it supplies key clinical trial data related to ongoing trials specific to these pipeline products, allowing for an assessment of their current status and potential real-world applications.
Lastly, recent developments within the Blood Glucose Meter segment/industry are highlighted, encompassing the latest advancements, innovations, and trends shaping the landscape. This comprehensive report serves as a valuable resource for industry professionals, researchers, and stakeholders seeking insights into this field.
Reasons to Buy
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Blood Glucose Meters under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Blood Glucose Meters Overview
3 Products under Development
3.1 Blood Glucose Meters – Pipeline Products by Stage of Development
3.2 Blood Glucose Meters – Pipeline Products by Segment
3.3 Blood Glucose Meters – Pipeline Products by Territory
3.4 Blood Glucose Meters – Pipeline Products by Regulatory Path
3.5 Blood Glucose Meters – Pipeline Products by Estimated Approval Date
3.6 Blood Glucose Meters – Ongoing Clinical Trials
4 Blood Glucose Meters – Pipeline Products under Development by Companies
4.1 Blood Glucose Meters Companies – Pipeline Products by Stage of Development
4.2 Blood Glucose Meters – Pipeline Products by Stage of Development
5 Blood Glucose Meters Companies and Product Overview
6 Blood Glucose Meters – Recent Developments
7 Appendix
A selection of companies mentioned in this report includes
4a Medicom GmbH
Abbott Diabetes Care Inc
Abbott Healthcare Pvt Ltd
Abbott Laboratories
Actxa Pte Ltd
Advanced Biosensors-Ohio LLC
Advanced Medical Electronics Corp
Afon Technology Ltd
Alertgy Inc
ALR Technologies Inc
Arkal Medical Inc (Inactive)
Azurite Technologies, Inc. (Inactive)
Bar-Ilan University
Baylor University
Biofi Medical Healthcare Pvt Ltd
BioGliko Sp zoo
Biolinq Inc
Biopeak Corp
Biorasis Inc
BioTex Inc
Biovotion AG
Brain Beat Ltd
Brigham and Women’s Hospital
Brighter AB
CALISTO MEDICAL, INC. (Inactive)
Callitas Therapeutics Inc
Cardiff University
CGM3 Ltd
Cirtec Medical Corp
City, University of London
Columbia University
ConvaTec Group Plc
Co-Optical Inc
Cyber Medical Ltd (Inactive)
DexCom Inc
DiaMonTech GmbH
DirectSens GmbH
Echo Therapeutics Inc
Ecole Polytechnique Federale de Lausanne
eLutions Integrated Systems, Inc.
Emperra GmbH E-Health Technologies
EyeSense GmbH
Firefly Health Pty Ltd
Flowsion A/S
Gili Medical Ltd
Globe Medical Tech Inc (Inactive)
GlucoLight Corporation (Inactive)
GlucoMe Ltd
Glucometrix AG
GlucoModicum Oy
Glucorecs
GlucoRx Ltd
Glucosat
Glucosense Diagnostics Ltd (Inactive)
GlucoSet AS
GlucoStats System Pte Ltd.
GlucoTrack Inc
Glucovation Inc
GluMetrics Inc
Glusense Ltd
GlySens Inc
G-Sense Ltd.
Guangzhou Powder Pharmaceuticals Ltd
Guided Therapeutics Inc
Hagar Tech
Helo Corp
iGlyko, Inc. (Inactive)
Indigo Diabetes NV
InLight Solutions Inc.
Innopharmax Inc
Innovosens AB
Integrated Medical Sensors
IntelliDx Inc (Inactive)
InventHelp
Invivomon Inc (Inactive)
Invivosense ASA (Inactive)
I-Sens Inc
iSense Corporation (Inactive)
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
KeenCAT Technologies
Keratin Biosciences Inc
Know Labs Inc
KTH Royal Institute of Technology
Lein Applied Diagnostics Limited
LEMM Technologies, LLC
Lifecare AS
LifeScan Inc
Light Touch Technology Co Ltd
LighTouch Medical, Inc.
Luminous Medical Inc (Inactive)
Lyte Labs
Massachusetts Institute of Technology
Medical Wireless Sensing Ltd
Medtronic MiniMed Inc
Medtronic Plc
Mellitor Ltd
Metronom Health Inc
MicroTech Medical Co Ltd
mobiLIFE
Mologic Ltd
Movano Inc
Nagasaki University
Nemaura Medical Inc
Newton Photonics Inc
NIR Diagnostics Inc. (Inactive)
Northwestern University
Occuity Ltd
Pelikan Technologies, Inc. (Inactive)
Pepex Biomedical, Inc.
PharmaTech Solutions Inc
PKvitality SAS
POPS! Diabetes Care Inc
PositiveID Corp
Profusa Inc
Provigate Inc
Purdue University
Q Step Technologies, Inc.
Quantum Operation Co Ltd
Roche Diabetes Care Inc
Sangui BioTech International Inc
Sanmina Corp
SD Biosensor Inc
Senseonics Holdings Inc
SensiVida Medical Technologies, Inc. (Inactive)
Sensys Medical, Inc.
Sentec Pte Ltd
Shenzhen Refresh Biosensing Technology Co Ltd
Shenzhen Sibionics Technology Co Ltd
Shield Diagnostics
Singapore Biomicro Pte Ltd
Socrates Health Solutions, Inc.
Solys Diagnostics Inc
Spire Biophotonics Lifesciences
St. Louis Medical Devices Inc (Inactive)
Stony Brook University
Swansea University
Tandem Diabetes Care Inc
TecMed Inc
Tenax Therapeutics Inc
Terumo Corp
Texas A&M University
Tonwo Health Clinic Technology Pty Ltd
Ultradian Diagnostics LLC
Umana Medical Technologies Ltd
University of Bordeaux
University of California Berkeley
University of California Irvine
University of California San Diego
University of Central Florida
University of South Carolina
University of South Florida
University of Technology Sydney
University of Texas at Arlington
Uxn Co Ltd
VeriTeQ Corporation
Virginia Commonwealth University
VivaLyf Innovations Pvt Ltd
Vytrace, Inc.
Weglo
Weitai Medical Equipment (Hangzhou) Co Ltd
Xcellence in Bio Innovations & Technologies Pvt Ltd
Zansors LLC
Zyvex Corp
For more information about this report visit https://www.researchandmarkets.com/r/n85f29
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
